These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
605 related articles for article (PubMed ID: 20826567)
1. Prevention of bleomycin-induced pulmonary fibrosis by a novel antifibrotic peptide with relaxin-like activity. Pini A; Shemesh R; Samuel CS; Bathgate RA; Zauberman A; Hermesh C; Wool A; Bani D; Rotman G J Pharmacol Exp Ther; 2010 Dec; 335(3):589-99. PubMed ID: 20826567 [TBL] [Abstract][Full Text] [Related]
2. Relaxin induces an extracellular matrix-degrading phenotype in human lung fibroblasts in vitro and inhibits lung fibrosis in a murine model in vivo. Unemori EN; Pickford LB; Salles AL; Piercy CE; Grove BH; Erikson ME; Amento EP J Clin Invest; 1996 Dec; 98(12):2739-45. PubMed ID: 8981919 [TBL] [Abstract][Full Text] [Related]
3. Prevention of bleomycin-induced lung inflammation and fibrosis in mice by naproxen and JNJ7777120 treatment. Rosa AC; Pini A; Lucarini L; Lanzi C; Veglia E; Thurmond RL; Stark H; Masini E J Pharmacol Exp Ther; 2014 Nov; 351(2):308-16. PubMed ID: 25185215 [TBL] [Abstract][Full Text] [Related]
4. Prevention of bleomycin-induced lung fibrosis in mice by a novel approach of parallel inhibition of cyclooxygenase and nitric-oxide donation using NCX 466, a prototype cyclooxygenase inhibitor and nitric-oxide donor. Pini A; Viappiani S; Bolla M; Masini E; Bani D J Pharmacol Exp Ther; 2012 May; 341(2):493-9. PubMed ID: 22344408 [TBL] [Abstract][Full Text] [Related]
5. VEGFR-2 antagonist SU5416 attenuates bleomycin-induced pulmonary fibrosis in mice. Ou XM; Li WC; Liu DS; Li YP; Wen FQ; Feng YL; Zhang SF; Huang XY; Wang T; Wang K; Wang X; Chen L Int Immunopharmacol; 2009 Jan; 9(1):70-9. PubMed ID: 18976720 [TBL] [Abstract][Full Text] [Related]
6. Activation of relaxin-related receptors by short, linear peptides derived from a collagen-containing precursor. Shemesh R; Hermesh C; Toporik A; Levine Z; Novik A; Wool A; Kliger Y; Rosenberg A; Bathgate RA; Cohen Y Ann N Y Acad Sci; 2009 Apr; 1160():78-86. PubMed ID: 19416163 [TBL] [Abstract][Full Text] [Related]
7. Heat shock protein 70 protects against bleomycin-induced pulmonary fibrosis in mice. Tanaka K; Tanaka Y; Namba T; Azuma A; Mizushima T Biochem Pharmacol; 2010 Sep; 80(6):920-31. PubMed ID: 20513440 [TBL] [Abstract][Full Text] [Related]
8. HGF reduces advancing lung fibrosis in mice: a potential role for MMP-dependent myofibroblast apoptosis. Mizuno S; Matsumoto K; Li MY; Nakamura T FASEB J; 2005 Apr; 19(6):580-2. PubMed ID: 15665032 [TBL] [Abstract][Full Text] [Related]
9. Inhibitory effect of emodin on bleomycin-induced pulmonary fibrosis in mice. Chen XH; Sun RS; Hu JM; Mo ZY; Yang ZF; Jin GY; Guan WD; Zhong NS Clin Exp Pharmacol Physiol; 2009 Feb; 36(2):146-53. PubMed ID: 18785980 [TBL] [Abstract][Full Text] [Related]
10. A novel inhibitor of Smad-dependent transcriptional activation suppresses tissue fibrosis in mouse models of systemic sclerosis. Hasegawa M; Matsushita Y; Horikawa M; Higashi K; Tomigahara Y; Kaneko H; Shirasaki F; Fujimoto M; Takehara K; Sato S Arthritis Rheum; 2009 Nov; 60(11):3465-75. PubMed ID: 19877032 [TBL] [Abstract][Full Text] [Related]
11. Relaxin receptor expression in hepatic stellate cells and in cirrhotic rat liver tissue. Bennett RG; Mahan KJ; Gentry-Nielsen MJ; Tuma DJ Ann N Y Acad Sci; 2005 May; 1041():185-9. PubMed ID: 15956705 [TBL] [Abstract][Full Text] [Related]
12. Feitai, a Chinese herbal medicine, reduces transforming growth factor-beta1 and monocyte chemoattractant protein-1 expression in bleomycin-induced lung fibrosis in mice. Shen Y; Zhao HL; Du J; Li YT; Tan F; Huang CG; Pei G Clin Exp Pharmacol Physiol; 2005 Dec; 32(12):1071-7. PubMed ID: 16445573 [TBL] [Abstract][Full Text] [Related]
13. H3 relaxin demonstrates antifibrotic properties via the RXFP1 receptor. Hossain MA; Man BC; Zhao C; Xu Q; Du XJ; Wade JD; Samuel CS Biochemistry; 2011 Mar; 50(8):1368-75. PubMed ID: 21229994 [TBL] [Abstract][Full Text] [Related]
14. Improved chemical synthesis and demonstration of the relaxin receptor binding affinity and biological activity of mouse relaxin. Samuel CS; Lin F; Hossain MA; Zhao C; Ferraro T; Bathgate RA; Tregear GW; Wade JD Biochemistry; 2007 May; 46(18):5374-81. PubMed ID: 17425335 [TBL] [Abstract][Full Text] [Related]
15. Antifibrotic action of pirfenidone and prednisolone: different effects on pulmonary cytokines and growth factors in bleomycin-induced murine pulmonary fibrosis. Oku H; Shimizu T; Kawabata T; Nagira M; Hikita I; Ueyama A; Matsushima S; Torii M; Arimura A Eur J Pharmacol; 2008 Aug; 590(1-3):400-8. PubMed ID: 18598692 [TBL] [Abstract][Full Text] [Related]
16. The D prostanoid receptor agonist BW245C [(4S)-(3-[(3R,S)-3-cyclohexyl-3-hydroxypropyl]-2,5-dioxo)-4-imidazolidineheptanoic acid] inhibits fibroblast proliferation and bleomycin-induced lung fibrosis in mice. van den Brule S; Wallemme L; Uwambayinema F; Huaux F; Lison D J Pharmacol Exp Ther; 2010 Nov; 335(2):472-9. PubMed ID: 20719937 [TBL] [Abstract][Full Text] [Related]
17. Attenuation of bleomycin-induced lung fibrosis in rats by mesna. El-Medany A; Hagar HH; Moursi M; At Muhammed R; El-Rakhawy FI; El-Medany G Eur J Pharmacol; 2005 Feb; 509(1):61-70. PubMed ID: 15713430 [TBL] [Abstract][Full Text] [Related]
18. Expression of RXFP1 Is Decreased in Idiopathic Pulmonary Fibrosis. Implications for Relaxin-based Therapies. Tan J; Tedrow JR; Dutta JA; Juan-Guardela B; Nouraie M; Chu Y; Trejo Bittar H; Ramani K; Biswas PS; Veraldi KL; Kaminski N; Zhang Y; Kass DJ Am J Respir Crit Care Med; 2016 Dec; 194(11):1392-1402. PubMed ID: 27310652 [TBL] [Abstract][Full Text] [Related]